drugset / Trial / NCT00822913
Botulinum A Toxin in Patients With Parkinson's Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The researchers investigated the effectiveness and safety of BoNT/A injected into the detrusor muscle in patients with PD and MSA all of whom had detrusor muscle overactivity unresponsive to conventional medical therapy.
Timeline
- Start
- 2008-06
- Primary completion
- 2008-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Other |